Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 04/18/16 → 02/15/18 |
Funding
- National Cancer Institute: $1.00
A Phase III Randomized Study of Nivolumab Plus Ipilimumab Versus Nivolumab for Previously Treated Patients with Stage IV Squamous Cell Lung Cancer and No Matching Biomarker
- Keresztes, Roger (PI)
- Zhang, Yue (CoPI)
Project: Research